Showing 1,201 - 1,220 results of 102,316 for search '(( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( 5 step decrease ))', query time: 1.45s Refine Results
  1. 1201

    PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues. by Hiromi Hyodo (484509)

    Published 2013
    “…One unit means a decrease in OD<sub>620</sub> per second. …”
  2. 1202
  3. 1203

    The expression of genes related to mitochondria was decreased in Pgam2 mice. by Junji Okuda (444322)

    Published 2013
    “…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …”
  4. 1204
  5. 1205
  6. 1206
  7. 1207
  8. 1208
  9. 1209

    Cdk5 Deficiency Affects Early Steps of Neuronal Maturation and Alters Dendritic Structure by Sebastian Jessberger (269496)

    Published 2008
    “…Scale bar represents 10 μm.</p> <p>(B) <i>DNcdk5</i> expression altered dendritic orientation and led to reduced dendritic length and decreased branching points, whereas <i>cdk5</i> overexpression had no effect on dendritic complexity. …”
  10. 1210
  11. 1211
  12. 1212
  13. 1213

    Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”
  14. 1214
  15. 1215

    Acute JMV2959 treatment decreases alcohol intake in rats. by Petra Suchankova (400313)

    Published 2013
    “…<p>(A) The acute effects of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) administration on alcohol intake was evaluated at 1 hour time interval after both two and five months of voluntary alcohol consumption. …”
  16. 1216
  17. 1217
  18. 1218
  19. 1219
  20. 1220

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …”